(PDF) Retraction: The Chemokine Receptor CXCR6 and Its

Retraction: The Chemokine Receptor CXCR6 and Its Ligand CXCL16 Are Expressed in Carcinomas and Inhibit Proliferation

Cancer Research - United States

doi 10.1158/0008-5472.can-10-4378

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

January 18, 2011

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

CXC Chemokine Receptor 6 (CXCR6); Chemokine CXC Motif Ligand 16 (CXCL16)

Science-Business eXchange

English

Homocysteine Up-Regulates Vascular Transmembrane Chemokine CXCL16 and Induces CXCR6+ Lymphocyte Recruitmentin Vitroandin Vivo

Journal of Cellular and Molecular Medicine

Molecular Medicine

English

CXCL16/CXCR6 Chemokine Signaling Mediates Breast Cancer Progression by pERK1/2-dependent Mechanisms

English

The Ephrin-A1 Ligand and Its Receptor, EphA2, Are Expressed During Tumor Neovascularization

Cancer Research

Molecular Biology

English

The Chemokine Cxcl16 Is Highly and Constitutively Expressed by Human Bronchial Epithelial Cells

Experimental Lung Research

Respiratory Medicine

Clinical Biochemistry

Molecular Biology

English

FLT-3 and Its Ligand Are Expressed in Neural Crest–Derived Tumors and Promote Survival and Proliferation of Their Cell Lines

Laboratory Investigation

Forensic Medicine

Molecular Biology

English

CXCL16/CXCR6 Interaction Promotes Endometrial Decidualization via the PI3K/ AKT Pathway

Reproductive Medicine

English

Chemokine CCL2 and Its Receptor CCR2 in the Medullary Dorsal Horn Are Involved in Trigeminal Neuropathic Pain

Journal of Neuroinflammation

Molecular Neuroscience

English

CXCL16 Is Expressed in Podocytes and Acts as a Scavenger Receptor for Oxidized Low-Density Lipoprotein

American Journal of Pathology

Forensic Medicine

English